Summary: Cigna Healthcare modified its hyperbaric and topical oxygen therapies coverage policy (policy 0053), effective May 16, 2026. Here's what billing teams need to do before that date.
Cigna Healthcare — the full official name matters when you're pulling EOBs and policy documents — updated policy 0053 governing hyperbaric oxygen therapy (HBOT) and topical oxygen therapy coverage. This is one of the more financially significant wound care policies in Cigna's book, and changes here tend to ripple through claim denial rates fast. The policy does not list specific CPT or HCPCS codes in the available data, so your team needs to pull the full policy document directly from Cigna to confirm which codes are governed by this revision before May 16, 2026.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Cigna Healthcare |
| Policy | Hyperbaric and Topical Oxygen Therapies (0053) |
| Policy Code | 0053 |
| Change Type | Modified |
| Effective Date | May 16, 2026 |
| Impact Level | High |
| Specialties Affected | Wound care, hyperbaric medicine, vascular surgery, plastic surgery, podiatry, infectious disease |
| Key Action | Audit all pending and active HBOT authorizations against the updated criteria before May 16, 2026 |
Cigna Hyperbaric Oxygen Therapy Coverage Criteria and Medical Necessity Requirements 2026
This is where you need to pay close attention. The Cigna hyperbaric and topical oxygen therapy coverage policy under 0053 has long been one of the more restrictive commercial payer positions on HBOT. The underlying pattern in these modifications is almost always the same: Cigna tightens what counts as "medically necessary" HBOT, expands the list of non-covered indications, or updates the documentation requirements for prior authorization.
Medical necessity is the fulcrum of every HBOT claim. Cigna's policy framework for these therapies requires that you demonstrate the condition meets specific clinical criteria — not just that a physician ordered the treatment. If the 2026 modification follows the pattern of Cigna's prior revisions to this policy, expect tighter language around wound staging, treatment duration limits, and failure of conventional therapy as a prerequisite.
Prior authorization is required for hyperbaric oxygen therapy under Cigna. That's been true across prior versions of this policy, and nothing in a "modified" designation suggests that requirement is going away. What changes in modifications like this are usually the specific clinical benchmarks that determine whether Cigna approves or denies the auth request.
Medical necessity documentation for HBOT claims should include wound measurement records, prior treatment history showing failure of standard wound care, and the treating physician's clinical rationale for initiating hyperbaric therapy. If your documentation package doesn't address each of these points, your prior auth is at risk before you even submit the claim.
Because the full text of the 0053 modification was not available in the policy data at the time of publication, verify the exact updated criteria directly at the Cigna policy source before May 16, 2026. If you're managing high HBOT volume and you're not sure how the updated language applies to your patient mix, loop in your compliance officer before the effective date.
Cigna Topical Oxygen Therapy: Exclusions and Non-Covered Indications
Topical oxygen therapy has historically sat in a different bucket than systemic HBOT under Cigna's coverage policy — and not a favorable one. Cigna has treated topical oxygen delivery as experimental or investigational for most wound care indications in prior versions of this policy.
The real issue here is that topical oxygen and systemic hyperbaric oxygen therapy are often conflated in clinical documentation, and that confusion costs you on claims. Cigna draws a sharp line between the two. Systemic HBOT — where the patient enters a pressurized chamber and breathes 100% oxygen — has a defined (if narrow) set of covered indications. Topical oxygen therapy, where oxygen is applied directly to a wound surface without systemic exposure, has faced much broader experimental designations.
If your wound care program uses topical oxygen devices, those claims are high-risk under the Cigna hyperbaric oxygen therapy coverage policy. Even if a physician considers it standard of care, Cigna's coverage position has not followed clinical practice in this area. Document your clinical rationale thoroughly, but don't expect that documentation alone to overcome an experimental designation at the payer level.
Check the updated 0053 policy text to confirm whether the May 2026 modification changed Cigna's stance on topical oxygen. Any shift there — even a partial one — would be meaningful for wound care billing.
Coverage Indications at a Glance
The specific indication-level criteria from the 2026 modification of policy 0053 were not available in the policy data provided. The table below reflects what Cigna's 0053 policy has historically covered and excluded, based on prior versions of this coverage policy. Confirm each row against the updated policy text before May 16, 2026.
| Indication | Historical Status | Notes |
|---|---|---|
| Diabetic foot wounds (Wagner Grade III or higher) | Covered (when criteria met) | Prior authorization required; must document failure of standard wound care |
| Chronic refractory osteomyelitis | Covered (when criteria met) | Requires documentation of inadequate response to antibiotics and surgical debridement |
| Compromised skin grafts and flaps | Covered (when criteria met) | Must document clinical necessity; timing relative to surgery matters |
| Necrotizing soft tissue infections | Covered (when criteria met) | Typically adjunctive to surgical treatment |
| Radiation tissue damage (osteoradionecrosis, radiation cystitis) | Covered (when criteria met) | Prior authorization required; documented radiation history needed |
| Carbon monoxide poisoning | Covered (emergency) | Often exempt from standard prior auth requirements |
| Air or gas embolism | Covered (emergency) | Same emergency carve-out typically applies |
| Topical oxygen therapy (wound care) | Not Covered / Experimental | Cigna has consistently designated this investigational |
| HBOT for TBI, cerebral palsy, stroke, autism | Not Covered / Experimental | Long-standing exclusion; no coverage for neurological indications |
| HBOT for anti-aging, cosmetic, or wellness uses | Not Covered | Not a medical necessity indication under any Cigna policy version |
| Venous stasis ulcers (without other qualifying criteria) | Not Covered (in most cases) | Review updated 0053 text for any change to this position |
Cigna Hyperbaric Oxygen Therapy Billing Guidelines and Action Items 2026
| # | Action Item |
|---|---|
| 1 | Pull the full 0053 policy text from Cigna before May 16, 2026. The modification is active on that date. You need the updated criteria in hand now — not on May 17 when your first denial comes back under the new language. Access the policy directly at Cigna's coverage position criteria library. |
| 2 | Audit all active HBOT prior authorizations. If you have patients mid-course in a hyperbaric series with active Cigna auths, check whether the approved authorization was issued under the old criteria. If the updated policy tightens session limits or medical necessity thresholds, you may need to re-document or re-authorize before the effective date of May 16, 2026. |
| 3 | Update your medical necessity documentation templates. Whatever your current intake checklist looks like for HBOT prior authorization, treat it as provisional until you've reviewed the 0053 update. Specifically confirm that your templates capture wound staging, prior treatment failure, and physician attestation in the format Cigna now requires. |
| 4 | Flag topical oxygen claims for compliance review. If your billing team submits topical oxygen therapy claims to Cigna, this policy change is a trigger to review those before submission. Topical oxygen reimbursement from Cigna is unlikely under any version of this policy, but confirm the updated text hasn't shifted that position. |
| 5 | Brief your wound care physicians on the updated criteria. HBOT denials don't start in billing — they start in clinical documentation. Your physicians need to know what Cigna now requires to support medical necessity before they order the therapy, not after a claim denial lands on your desk. |
| 6 | Check for any changes to hyperbaric oxygen therapy billing timelines. Some payer policy modifications adjust session caps or require reassessment at specific treatment milestones. If 0053 now includes session limits (e.g., requiring documentation of wound progress at 20 or 30 treatments), your billing team needs to build those checkpoints into your workflow. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Hyperbaric and Topical Oxygen Therapies Under Policy 0053
The available policy data for this modification does not include specific CPT, HCPCS, or ICD-10 codes. Do not assume which codes are governed by policy 0053 without reviewing the full Cigna policy document.
That said, hyperbaric oxygen therapy billing typically involves a defined set of procedure codes that your team should verify against the updated policy. Pull the current Cigna coverage position document for 0053 and confirm which codes are explicitly addressed, covered, or excluded.
When you review the full policy, pay attention to:
- Procedure codes for hyperbaric chamber sessions (both hospital outpatient and independent wound care center settings)
- HCPCS codes for topical oxygen delivery devices, if any are listed
- Diagnosis codes that Cigna accepts as qualifying indications — these are often listed explicitly in the coverage criteria section of the policy
If your team needs help mapping your charge master to the updated 0053 criteria, your billing consultant or a certified wound care billing specialist can cross-reference your current code set against what the policy allows. Don't guess on code applicability when Cigna's 0053 has this level of financial exposure in wound care programs.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.